13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008264
Total Value
$51.9M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,266,934 | $38.6M | 74.30% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 1,008,116 | $8.9M | 17.17% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $4.4M | 8.53% |